keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BIM-23190 is a somatostatin analog that acts as a selective agonist for SSTR2 and SSTR5 receptors. It displays potency with K i values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 finds utility in cancer and acromegaly research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 970.00 |
Description | BIM-23190 is a somatostatin analog that acts as a selective agonist for SSTR2 and SSTR5 receptors. It displays potency with K i values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 finds utility in cancer and acromegaly research. |
In vitro | BIM-23190 tends to mildly stimulate PRL secretion[1]. |
In vivo | BIM-23190, administered at a dosage of 50 μg per mouse twice daily, demonstrated notable anti-tumor activity against C6 glioma in a study involving male athymic nude (nu/nu) mice aged 5-6 weeks. Over a 19-day period, the injections significantly reduced the growth rate of the tumors. |
Molecular Weight | 1202.46 |
Formula | C57H79N13O12S2 |
CAS No. | 182153-96-4 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BIM-23190 182153-96-4 BIM 23190 BIM23190 inhibitor inhibit